Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
12/2007
12/21/2007WO2007144370A1 New chemical compounds
12/21/2007WO2007081517A3 Anti-viral compounds
12/21/2007CA2655085A1 Cgrp receptor antagonists
12/21/2007CA2654722A1 Thiadiazole compounds and methods of use thereof
12/21/2007CA2654212A1 New chemical compounds
12/20/2007US20070293512 2-[4-(4-Chlorophenylthio)-3-nitrophenyl]-4-mercaptothiazolo[5,4-d]pyrimidine; hyperuricemia; gout
12/19/2007EP1866310A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
12/19/2007EP1771450B1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007CN101090883A Substituted hydroxyethylamines
12/19/2007CN101089000A Spiro piperazine quaternary ammonium salt compound and its prepn and application
12/19/2007CN100355758C Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists
12/18/2007US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
12/13/2007WO2007064797A3 Inhibitors of c-met and uses thereof
12/13/2007US20070287701 6-({[(1-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
12/13/2007CA2654445A1 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
12/13/2007CA2651550A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase
12/12/2007EP1864984A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring
12/12/2007EP1864982A1 Triamine derivative
12/12/2007EP1863812A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
12/12/2007EP1863774A2 Heterocyclical chromophore architectures with novel electronic acceptor systems
12/12/2007EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
12/12/2007EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
12/12/2007EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY
12/12/2007CN101087798A Sulfonamido-macrocycles as tie2 inhibitors
12/12/2007CN101087797A Sulfonamido-macrocycles as tie2 inhibitors
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN100354282C Thienopyridazinones and their use in modulation of autoimmune disease
12/12/2007CN100354281C Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines
12/11/2007US7307165 Process for producting imidazo[1,2-b]pyridazine derivative
12/11/2007US7307085 Mitotic kinesin inhibitors
12/11/2007US7307075 Tetrahydroquinoline analogues as muscarinic agonists
12/11/2007US7307044 Use as insecticides, fungicides and/or herbicides; e.g. 3-(2-methyl-5-(4-chloro-phenyl)phenyl)-3-chloro-5,5-dimethyl-pyrrolidin-2,4-dione
12/06/2007WO2007115315A3 Pyrrolo- and thiazolo-pyridine compounds as hif modulators
12/06/2007US20070282103 Process for the Preparation of Thiazolopyrimidines
12/06/2007US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
12/06/2007US20070281930 bicyclic bisamides for controlling acarina
12/06/2007CA2647597A1 Thiazole compounds as cannabinoid receptor ligands and uses thereof
12/05/2007CN101081845A Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
11/2007
11/29/2007WO2007134958A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/29/2007WO2007094912A3 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
11/29/2007WO2007059341A3 Pyrazolothiazole protein kinase modulators
11/29/2007WO2006106326A8 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/29/2007US20070275984 Novel Thieno-Pyridine and Thieno-Pyrimidine Derivatives and Their Use as Positive Allosteric Modulators of Mglur2-Receptors
11/29/2007US20070275973 Aryl fused azapolycyclic compounds
11/29/2007CA2651769A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/28/2007EP1858901A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/28/2007EP1858900A1 Fused thiazole derivatives having affinity for the histamine h3 receptor
11/28/2007EP1858899A1 Heterobicyclic acrylamides
11/28/2007CN101080411A Thiazolopyridinone derivates as MCH receptor antagonists
11/28/2007CN100351258C Crystals of quinolinecarboxylic acid derivative solvate.
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7300949 For therapy of allergic disorders (e.g., immunodeficiency diseases and hypersensitivity); cardiovascular disorders (e.g., hypertension and arteriosclerosis); dental and oral disorders (e.g., inflammation of the oral mucosa); dermatologic disorders (e.g., dermatitis and skin infections)
11/27/2007US7300946 For use in controlling insects; controlling tobacco budworm
11/22/2007WO2007077961A3 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
11/22/2007US20070270586 Novel crystal of 7-[2-[(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270417 Antibacterial Agents
11/22/2007US20070270402 (+) or (-)-9-(piperazin-1-yl)-9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepine; schizophrenia, paranoid states, manic-depressive states, social regression, personality regression, hallucination, appetite disorders
11/22/2007US20070270401 Thiazolyl-Dihydro-Indazole
11/21/2007EP1856132A1 Process for preparing substituted benzothiazinoindoles
11/21/2007EP1578425B1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007CN101076532A Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
11/21/2007CN101076531A Carboxylic acid peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101074236A N,N-bi-substituted-methylpyrazole (4,5,e) (2,1,3)-thiadiazine-2,2,4-triketone derivative, its production and use
11/21/2007CN100349517C Fused heterocyclic sulfonylurea compound, herbicide containing the same and method of controlling weed with the same
11/20/2007CA2451754C Thienothiazine compounds having anti-inflammatory and analgesic activities and their preparation methods and the use thereof
11/15/2007WO2007070600A3 N-(5-membered heteroaromatic ring)-amido anti-viral compounds
11/15/2007WO2006122319A3 Histone deacetylase inhibitors
11/15/2007US20070265319 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
11/15/2007US20070265297 Thiazolopyridine Derivatives, Pharmaceut Ical Conditions Containing Them And Methods Of Treating Glucokinase Mediated Conditions
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265253 non-steroidal antiinflammatory agents such as 4H-Pyrido[2,3-g][1,4]benzothiazine-5,10-dione-1,1-dioxo-7-carboxylic acid, useful for treating inflammatory diseases or disorders
11/15/2007US20070265249 Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction
11/15/2007US20070262298 Photosensing soluble organic semiconductor material
11/14/2007EP1853610A1 N-phenyl benzamide derivatives as sirtuin modulators
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1853573A1 Benzisothiazoles useful for treating or preventing hcv infection
11/14/2007CN101072770A Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
11/14/2007CN101070327A Prulifloxacin and its key intermediate NM441 preparing method
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/13/2007US7294715 E.g., 2,9-Diisopropyloxy-1,10-dimethoxy-7-oxoaporphine and 1-methoxy-2-hydroxy-9,10-methylenedioxyaporphine; are used to treat ischemic and metabolic diseases
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125692A1 Material for organic electroluminescence element, and organic electroluminescence element
11/08/2007WO2007104485A3 Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259855 Thiazolyl-dihydro-indazole
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/07/2007EP1851232A2 Dihydroimidazothiazole derivatives
11/07/2007EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
11/07/2007CN101068809A Substituted indole compounds and their use as 5-ht6 receptor modulators
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 152